| 1 |
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al. · The Lancet
Open access191 authors |
Dec 2012 |
14,344 |
| 2 |
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S Lim et al. · The Lancet
Open access209 authors |
Dec 2012 |
12,027 |
| 3 |
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J L Murray et al. · The Lancet
Open access362 authors |
Dec 2012 |
9,055 |
| 4 |
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al. · The Lancet
Open access358 authors |
Dec 2012 |
8,461 |
| 5 |
The Global Burden of Cancer 2013
Christina Fitzmaurice et al. · JAMA Oncology
Open access132 authors |
28 May 2015 |
2,767 |
| 6 |
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Shiv Kumar Sarin et al. · Hepatology International
Open access |
13 Nov 2015 |
2,603 |
| 7 |
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly, Julian D Druce, Mike G Catton et al. · Antiviral Research
Open access |
3 Apr 2020 |
2,278 |
| 8 |
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D Stanaway et al. · The Lancet
Open access |
7 Jul 2016 |
1,388 |
| 9 |
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Paul K Nelson, Bradley M. Mathers, Benjamin Cowie et al. · The Lancet
ReviewOpen access |
29 Jul 2011 |
1,277 |
| 10 |
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan, Thi H. O. Nguyen, Marios Koutsakos et al. · Nature Medicine
Open access |
16 Mar 2020 |
1,107 |
| 11 |
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun‐Fan Liaw, Jia‐Horng Kao, Teerha Piratvisuth et al. · Hepatology International
|
16 May 2012 |
1,042 |
| 12 |
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Christopher J L Murray et al. · The Lancet
Open access366 authors |
21 Jul 2014 |
998 |
| 13 |
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini et al. · Gastroenterology
Open access |
Jun 2004 |
916 |
| 14 |
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun‐Fan Liaw, Nancy Leung, Jia‐Horng Kao et al. · Hepatology International
Open access |
9 May 2008 |
872 |
| 15 |
Hepatitis B virus infection
Man‐Fung Yuen, Ding‐Shinn Chen, Geoffrey M Dusheiko et al. · Nature Reviews Disease Primers
Review |
6 Jun 2018 |
836 |
| 16 |
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Giovanni Raimondo et al. · Journal of Hepatology
|
Aug 2008 |
834 |
| 17 |
The Global Circulation of Seasonal Influenza A (H3N2) Viruses
Colin A. Russell et al. · Science
|
17 Apr 2008 |
758 |
| 18 |
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Fabien Zoulim, STEPHEN A LOCARNINI · Gastroenterology
Open access |
7 Sep 2009 |
710 |
| 19 |
A New Arenavirus in a Cluster of Fatal Transplant-Associated Diseases
Gustavo F. Palacios, Julian D Druce, Lei Du et al. · New England Journal of Medicine
Open access |
6 Feb 2008 |
707 |
| 20 |
Global circulation patterns of seasonal influenza viruses vary with antigenic drift
Trevor Bedford et al. · Nature
Open access |
8 Jun 2015 |
689 |
| 21 |
Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
Björn F. Koel, David F. Burke, Theo M. Bestebroer et al. · Science
Open access |
21 Nov 2013 |
677 |
| 22 |
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe et al. · Journal of General Virology
Open access |
22 Jun 2020 |
643 |
| 23 |
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Josephine M. Bryant et al. · Science
Open access |
11 Nov 2016 |
603 |
| 24 |
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al. · Journal of Virology
Open access |
13 May 2009 |
599 |
| 25 |
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Giovanni Raimondo et al. · Journal of Hepatology
Open access |
17 Apr 2019 |
574 |
| 26 |
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
Peter Angus, Rhys Vaughan, Shelly Xiong et al. · Gastroenterology
|
Aug 2003 |
569 |
| 27 |
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine
Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy
Open access |
24 Aug 2004 |
539 |
| 28 |
Antibody landscapes after influenza virus infection or vaccination
Judith M. Fonville et al. · Science
Open access |
20 Nov 2014 |
526 |
| 29 |
A global scientific strategy to cure hepatitis B
Peter A. Revill et al. · The Lancet. Gastroenterology & hepatology
Open access |
10 Apr 2019 |
515 |
| 30 |
Molecular Virology of Hepatitis B Virus
STEPHEN A LOCARNINI · Seminars in Liver Disease
|
Feb 2004 |
514 |
| 31 |
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell, Man‐Fung Yuen, Henry Lik‐Yuen Chan et al. · Science Translational Medicine
Open access |
27 Sep 2017 |
499 |
| 32 |
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
David Stucki et al. · Nature Genetics
Open access |
31 Oct 2016 |
494 |
| 33 |
Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis
Akosua Adom Agyeman, Ken Lee Chin, Cornelia B. Landersdorfer et al. · Mayo Clinic Proceedings
ReviewOpen access |
6 Jun 2020 |
478 |
| 34 |
Antiviral drug-resistant HBV
Anna S. Lok, Fabien Zoulim, STEPHEN A LOCARNINI et al. · Hepatology
Open access |
27 Jun 2007 |
449 |
| 35 |
Global Phylogeny ofMycobacterium tuberculosisBased on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set
Ingrid Filliol et al. · Journal of Bacteriology
Open access |
29 Dec 2005 |
437 |
| 36 |
Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998
Betty Ann Brown, M. Steven Oberste, James P. Alexander et al. · Journal of Virology
Open access |
Dec 1999 |
433 |
| 37 |
Overview of hepatitis B viral replication and genetic variability
Shuping Tong, Peter A. Revill · Journal of Hepatology
Open access |
Apr 2016 |
431 |
| 38 |
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson, Tin Quang Nguyen, David M. Iser et al. · Hepatology
Open access |
Feb 2010 |
410 |
| 39 |
New hepatitis viruses: Contenders and pretenders
Scott Bowden · Journal of Gastroenterology and Hepatology
Open access |
Feb 2001 |
409 |
| 40 |
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
Manzour Hernando Hazbón, Michael B Brimacombe, Miriam Bobadilla del Valle et al. · Antimicrobial Agents and Chemotherapy
Open access |
26 Jul 2006 |
388 |
| 41 |
The role of quantitative hepatitis B surface antigen revisited
Markus Cornberg, Vincent Wai‐Sun Wong, STEPHEN A LOCARNINI et al. · Journal of Hepatology
|
2 Sep 2016 |
386 |
| 42 |
Perinatal transmission of hepatitis B virus: an Australian experience
Elke Wiseman, Melissa A. Fraser, Sally Holden et al. · The Medical Journal of Australia
|
May 2009 |
380 |
| 43 |
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community
Trang T. Vu, STEPHEN J. FARISH, Mark A. Jenkins et al. · Vaccine
Review |
Mar 2002 |
378 |
| 44 |
Structural organization of the hepatitis B virus minichromosome
C.–Thomas Bock, Susanne Schwinn, Stephen Locarnini et al. · Journal of Molecular Biology
|
Mar 2001 |
368 |
| 45 |
Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use
Arnold S. Monto, Jennifer L. McKimm‐Breschkin, Catherine A. Macken et al. · Antimicrobial Agents and Chemotherapy
|
26 Jun 2006 |
365 |
| 46 |
Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia
Leon Caly, Julian D Druce, Jason Alexander Roberts et al. · The Medical Journal of Australia
Open access |
Apr 2020 |
351 |
| 47 |
Hepatitis B Virus Epidemiology
Jennifer H MacLachlan, B. C. Cowie · Cold Spring Harbor Perspectives in Medicine
Open access |
May 2015 |
349 |
| 48 |
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
Tin Quang Nguyen, Alexander J. V. Thompson, Scott Bowden et al. · Journal of Hepatology
|
17 Feb 2010 |
348 |
| 49 |
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Kumar Visvanathan, Narelle A. Skinner, Alexander J. V. Thompson et al. · Hepatology
|
22 Dec 2006 |
340 |
| 50 |
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Georgina Paizis, Christos Tikellis, Mark Emmanuel Cooper et al. · Gut
Open access |
15 Sep 2005 |
339 |